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Patterns (PAMPs) and Danger Associated Molecular 
Patterns (DAMPs), which are released after cellular stress 
or damage. PRRs trigger different cellular signalling 
pathways, resulting in inflammation. Key actors in this 
immune surveillance are cytosolic protein complexes 
termed inflammasomes. Inflammasomes regulate the 
activity of caspase-1, which subsequently controls the 
production of pro-inflammatory cytokines and cell 
death. Although most of the research has focused on 
the prototype inflammatory caspase, caspase-1, recent 
data has highlighted major roles for caspase-11 in innate 
immunity through its ability to modulate inflammasome 
activation and cell death.
The inflammatory caspases 
in humans and mice
Caspases are cysteine proteases synthesized as inactive 
zymogens requiring proteolytic processing for activation. 
They can be subdivided into two groups, apoptotic caspases 
and inflammatory caspases [1]. Whereas apoptotic 
caspases are well conserved throughout evolution, 
inflammatory caspases are less conserved as they appear 
in the vertebrate lineage [2]. Inflammatory caspases play a 
prominent role in innate immunity. In Homo sapiens (Hs), 
the main inflammatory caspases consist of caspase-1, -4, 
and -5 (hcaspase-12 carries mutation giving rise to a non-
functional enzyme), while in Mus musculus (Mm) there are 
caspase-1, -11 and -12 (Figure 1) [3,4]. In both species these 
caspases are located within the same locus, chromosome 
11q22 for Hs and chromosome 9A1 for Mm. Genetic 
analysis suggested that human and mouse caspase-1 are 
orthologues whereas caspase-4 and -5 could originate 
from the duplication of a caspase-11-like ancient gene [5]. 
The major substrates of the inflammatory caspase-1 
are pro-Interleukin-1β (pro-IL-1β) and pro-IL-18, two 
important pro-inflammatory cytokines. Inflammatory 
caspases are mainly initiator caspases. Like apoptotic 
initiator caspases, they exhibit a death fold-containing 
CARD prodomain (Caspase Activation and Recruitment 
Domain) suggesting their recruitment and activation 
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Introduction
An efficient immune response depends on the 
inflammatory cascade that is orchestrated by the innate 
immune system. Innate immunity relies on the activity 
of germline-encoded Pathogen Recognition Receptors 
(PRRs) in surveying the extracellular and intracellular 
space for any signs of pathogen invasion or tissue 
injury. These sensors detect highly conserved motifs in 
pathogens, known as Pathogen Associated Molecular 
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within multiprotein complexes. Among inflammatory 
caspases, caspase-1 is the only member whose activation 
within a molecular platform, the inflammasome, has been 
well-documented [6]. Little is known about the modes 
of activation, functions, and substrates of caspase-4, 
-5, -11 and -12. Caspase-5 was proposed to be part of the 
inflammasome, but little work has corroborated this early 
observation [6]. Recent studies using different caspase-12-
deficient mouse models led to conflicting observations. 
Although some data suggested that caspase-12 may 
participate in endoplasmic reticulum stress-induced 
apoptosis, other studies suggested it acts as a negative 
regulator of inflammation by impairing caspase-1 function 
[7,8]. Before 2011, little was known about caspase-11 
function in inflammation except that it participates in 
the inflammatory response by controlling caspase-1 
activation upon lipopolysaccharide (LPS) stimulation 
[9]. Since then, caspase-11 has emerged as a new focus in 
the inflammation field with new functions, which will be 
described below.
General overview of the 
inflammasomes
The term inflammasome was first proposed in 2002 by 
Martinon and Tschopp to describe a caspase-1-activating 
platform resulting from the assembly of a protein complex 
that includes the PRR NLRP1 [6]. Since then, different NLR 
(e.g. NLRP3, NLRC4, NLRP6, NLRP12) and PYHIN (AIM2) 
family members have been shown to form inflammasomes 
[10-15]. The human NLR family is composed of twenty-
two members sharing a similar structural organisation: 
a N-terminal interacting domain, followed by a central 
Nucleotide Oligomerization Domain (NOD) and a C-terminus 
Leucine-Rich Repeat (LRR) motif. The LRRs behave as a 
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Figure 1: Overview of apoptotic and inflammatory caspases. (a) Schematic view of the structural organisation of human apoptotic and 
inflammatory caspases; L, large subunit, S, short subunit. CARD, Caspase Activation and Recruitment Domain, DED, Death Effector Domain. 
* non functional in human. (b) Phylogenic analysis of mouse and human inflammatory caspases based on full sequences. 
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sensing module and interact with NOD to keep the receptor 
in an inactive monomeric state [16,17]. Most PRRs involved 
in inflammasome formation contain at their N-terminus a 
PYD (in the case of NLRPs and AIM2) or a CARD domain 
(in the case of NLRC4). Once oligomerized, the scaffolding 
receptors recruit the adaptor protein, Apoptosis-associated 
Speck-like protein containing a CARD (ASC), which recruits 
caspase-1 molecules, resulting in a local increase in 
caspase-1 concentration and activation. NLRC4 contains a 
CARD domain that can directly interact with caspase-1 to 
induce cell death. However, ASC is required for efficient 
NLRC4-dependent caspase-1 auto-processing and IL-1β 
secretion [11,18-20]. 
Inflammasomes assemble in the cytosol in a stimulus-
specific manner. The NLRP3 inflammasome is assembled 
in response to a plethora of pathogens, including bacteria 
such as Staphylococcus aureus, viruses such as Influenza 
virus, and fungi Candida albicans [21-23]. In addition, 
DAMPs such as extracellular ATP, MonoSodium Urate 
(MSU) and cholesterol crystals, as well as airborne 
pollutants, such as silica or asbestos, were shown to induce 
NLRP3 inflammasome activation [23-26]. The hNLRP1 
inflammasome senses Muramyl Di-Peptide (MDP), while 
murine NLRP1b is activated by Bacillus anthracis lethal 
toxin [27,28]. NLRP12 recognizes Yersinia pestis bacteria, 
the causative agent of the plague, and NLRP6 is implicated 
in the maintenance of the commensal microbiota [12,13]. 
AIM2 senses cytosolic double-stranded DNA, while NLRC4 
senses cytosolic bacterial flagellin and type III secretion 
system components [14,19,29,30]. After integration of 
activating signals,  inflammasomes are involved in the 
activation and release of mature IL-1β and IL-18, inducing 
the recruitment of immune cells at the site of infection or 
damage. In addition, inflammasome activation can result 
in a caspase-1-dependent cell death called pyroptosis, 
crucial to pathogen clearance and characterized by cell 
swelling and the release of inflammatory factors such as 
IL-1α and IL-1β [31]. 
Caspase-11 and the discovery of the 
noncanonical inflammasome
Two key observations led to the recent breakthroughs 
in caspase-11 biology. First, mice genetically engineered 
to inactivate caspase-1 expression were also found to be 
deficient for caspase-11 expression [32,33]. The second 
observation, made by Kayagaki and Dixit, was that 
murine macrophages isolated from 129 strains were 
insensitive to Cholera Toxin B (CTB) and LPS stimulation, 
a treatment they demonstrated to specifically engage 
caspase-11 in sensitive strains such as C57BL/6. Although 
many research laboratories work with C57BL/6 caspase-1 
knockout (KO) colonies, the ES cells used in the past 
to generate knockout mice originate from 129 strains. 
These strains appear to carry inactivating mutations in 
the caspase-11 locus resulting in the absence of caspase-
11 protein. As caspase-1 and caspase-11 are adjacent on 
the mouse chromosome 9, it is unlikely that these genes 
could segregate by recombination upon backcrossing. 
Therefore, the caspase-1 KO mice used thus far in all 
studies are casp1/11 double KO [34,35].
The use of macrophages isolated from the 
C57BL/6 caspase-11- or caspase-1/11-deficient mice 
complemented with a caspase-11 transgene (caspase-
1-/-caspase-11tg) revealed that upon Gram-negative 
bacterial infection, caspase-11 is critical for both 
caspase-1 dependent cytokine maturation and 
caspase-1 independent pyroptosis. Upon stimulation 
with CTB and LPS or Gram-negative bacteria, such as 
Vibrio cholera (Vc), Escherichia coli (Ec) or Citrobacter 
rodentium (Cr), caspase-11 activation contributes to 
the production of mature IL-1β and IL-18 through the 
NLRP3 inflammasome [32,36,37]. However, the NLRP3 
inflammasome activity is not required for bacterial-
mediated caspase-11 cell death associated with IL-1α, 
HMGB1, and LDH release (Figure 2). Furthermore, 
caspase-11 is not involved in inflammasome formation 
in response to the well-characterized NLRP3 agonists 
or Gram-positive bacteria. These observations led the 
Dixit laboratory to employ the term “noncanonical 
inflammasome” to designate an unknown caspase-
11 activating platform that, on one hand, controls 
caspase-1 activation and cytokine processing, and on 
the other hand, induces cell death independently of 
caspase-1. Since then, other groups have supported and 
extended this concept to other Gram-negative bacterial 
strains such as Salmonella typhimurium (St), Legionella 
pneumophila (Lp) or Yersinia pseudotuberculosis (Yp) 
[39-42]. St differs from Vc, Ec and Cr in that IL-1β and 
IL-18 production (through both NLRP3 and NLRC4 
inflammasomes) is only partially dependent on 
caspase-11. 
Novel activators of caspase-11 
Caspase-11 is activated by most Gram-negative bacteria as 
well as by the combination of CTB and LPS. Gram-negative 
bacteria share in common the presence of LPS on their 
outer membranes, a well-known ligand of the Toll-Like 
Receptor 4 (TLR4) [43]. Recent investigations revealed 
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that the caspase-11 noncanonical inflammasome is 
triggered by cytosolic LPS (cLPS) in a TLR4-independent 
manner [44,45]. Transfection or electroporation of LPS 
in murine macrophages, including TLR4-/- macrophages, 
resulted in caspase-11-dependent caspase-1 activation 
and IL-1β processing as well as caspase-1-independent 
pyroptosis. Detailed biochemical analysis demonstrated 
that the LPS moiety lipid A is a potent caspase-11 activator. 
In fact, only penta-acylated or hexa-acylated lipid A 
triggers the caspase-11 pathway, whereas tetra-acylated 
lipid A does not. This structural modification of lipid A is 
a strategy employed by specific bacterial strains, such as 
Francisella novicida and Helicobacter pylori, to evade the 
immune system in order to hinder caspase-11 activation. 
Mechanisms leading to caspase-11 
activation 
Until recently, few studies addressed the regulation and 
activation of caspase-11. Unlike caspase-1 and apoptotic 
caspases, caspase-11 expression is inducible. Although 
caspase-11 is difficult to detect in resting macrophages, 
its expression was originally shown to be inducible 
upon exposure to LPS [9]. Recently, it was observed 
that the TLR pathway adaptors TRIF and MyD88 are 
required for full caspase-11 expression, suggesting that 
its induction is regulated by upstream TLR pathways 
[32,40-42,44]. The molecular pathways involved in 
caspase-11 activation are not yet fully understood and 
Figure 2: Pathways under caspase-11 control in response to Gram-negative bacteria. Sensing of Gram-negative bacteria by TLRs results 
in the activation of NFκB and IRF3 transcription factors through the TLR-adaptor proteins MyD88 and Trif. NFκB induces the transcription 
of pro-IL-1β, NLRP3, caspase-11 and a putative unknown receptor, whereas IRF3 transcriptional activity leads to the production of Type I 
IFN. Type I IFN signals through IFNAR pathway, which participates in caspase-11 production and leads to the transcription of an unknown 
caspase-11 activator. Detection of cytosolic LPS by a putative receptor or the production of an unknown activator leads to the processing 
and activation of caspase-11. Once active, caspase-11 induces cell-death associated with IL-1α and HMGB1 release; active caspase-11 also 
contributes to caspase-1 activation, within the NLRP3 inflammasome, resulting in IL-1β and IL-18 maturation and release.
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different mechanisms may underlie its response to 
different pathogens. 
Using Ec or Cr enteropathogens, Rathinam et al. 
described that caspase-11 expression is sufficient to 
trigger its autoactivation. In macrophages, the sensing 
of these enteropathogens by the NLRP3 inflammasome 
and the noncanonical inflammasome is dependent on the 
TLR4/TRIF pathway. In mouse macrophages, caspase-11 
is upregulated by type I IFN (Figure 2). The absence of 
IFNARI or STAT1 results in impaired levels of caspase-
11 and as a consequence absence of IL-1β and IL-18 
maturation and secretion, and caspase-11 dependent 
pyroptosis [37,46]; this defect can be circumvented by the 
addition of recombinant IFN-β. 
However, other studies reported that up-regulation of 
caspase-11 is not sufficient to induce its processing. Trif-/- 
macrophages present a defective caspase-11 activation 
upon St infection, despite consistent levels of caspase-11 
[42]. Furthermore, caspase-11-dependent pyroptosis and 
IL-1β processing are also impaired in Irf3-/-, Ifnr1-/- and Stat1-
/- macrophages, despite capase-11 is expressed in the cells. 
Intriguingly, addition of exogenous type I IFN during St 
infection restored caspase-11 activation in the Trif-deficient 
cells. These data suggest the existence of an interferon-
inducible activator of caspase-11 (Figure 2). This mechanism 
was also described in response to flagellin-deficient Lp 
infection. Thus, according to these observations, caspase-
11 activation is not triggered by its expression but requires a 
second signal, for instance IFN type I signal, for licensing. Of 
note, cLPS or WT Lp activate the noncanonical inflammasome 
in Bone-Marrow Derived Macrophages (BMDM) lacking 
either Tlr4, Trif or Ifnar. cLPS induces IL-1β release and cell 
death in the absence of any priming signal, though the levels 
of IL-1β are lower than in primed cells and the kinetics are 
slower than infection by live bacteria [43]. Thus, it is likely 
that efficient caspase-11 activation relies on an unknown 
activator or receptor. Finally, it is not fully understood how 
caspase-11 activates the NLRP3 inflammasome and why it is 
specific to the NLRP3 inflammasome. It was described in the 
absence of caspase-11, and in response to Ec or Cr, that ASC 
molecules were still able to oligomerize and recruit caspase-1 
[36]. In response to LPS and CTB or to infection, caspase-1 
and caspase-11 were shown to physically interact, therefore 
it is possible that caspase-11 catalyses caspase-1 activation 
within the inflammasome complex [9,32,33]. However, 
mutant St, which exclusively engages caspase-11 for cell 
toxicity, could not induce ASC oligomerization in absence of 
caspase-11 [41]. Therefore, more experiments are required to 
clarify how caspase-11 contributes to caspase-1 activation and 
to understand the implications for NLRP3 inflammasome 
activity.
In vivo functions of caspase-11
Caspase-11 is proposed to protect the host from bacteria 
escaping the phagosome and accessing and replicating 
in the cytosol [38]. Moreover, in vivo experiments 
performed using both caspase-11-deficient mice and 
caspase-1-/-caspase-11tg mice revealed that caspase-11, 
and not caspase-1, is the main effector of endotoxic (LPS) 
shock lethality [32]. In fact, TLR4-deficient mice primed 
with a TLR3 ligand succumb to secondary LPS challenge, 
whereas caspase-11-deficient mice are less sensitive to 
LPS treatment [43,44]. These findings suggest that the 
past interpretations made using the caspase-1/11-/- mice in 
different sepsis models should be revisited. Nonetheless, 
ASC-/- and NLRP3-/- mice were shown to be protected from 
LPS treatment (Mariathasan et al., 2004, 2006). Thus, it 
remains to be determined if NLRP3, ASC and caspase-11 
work together in the same pathway in vivo. Surprisingly, 
in response to oral St infection, caspase-11 activation in 
absence of caspase-1 is detrimental to the host as more 
bacterial load was found in the spleen, liver and mesenteric 
lymph nodes of caspase-1-/-caspase-11tg compared with 
WT or caspase-11-/- mice. This increased burden was most 
likely due to impaired neutrophil function in caspase-1-/-
caspase-11tg [41]. Thus, caspase-11 activation in absence 
of caspase-1 could represent a breach used by some 
pathogens to cause host disease.
Concluding remarks
During bacterial infection, different sensing systems 
cooperate to detect and control infections. TLR and NLR 
recognize specific PAMPs located in different cellular 
compartments. Bacteria or PAMPs reaching the cytosol 
are detected by different inflammasomes. Recent data 
unravel a new role for caspase-11 in the control of 
Gram-negative bacterial infection and inflammasome 
activation. Through sensing of cLPS, caspase-11 engages 
a noncanonical inflammasome that controls caspase-1 
activation, and a caspase-1 independent cell death [43,46]. 
The caspase-11 pathway appears to constitute an ingenious 
cellular mechanism allowing the detection by the host 
of intracellular pathogens that escape sensing by the 
canonical inflammasomes. Indeed, caspase-11 activation 
results in IL-1β processing by caspase-1 and cell death upon 
infection by Gram-negative pathogens including mutant 
strains that are deficient in PAMPs, such as flagellin. The 
mechanisms whereby caspase-11 is activated are still not 
fully understood. Whether caspase-11 is auto-processed 
when present in the cells at a threshold concentration 
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or whether it requires an activator or a platform remains 
to be elucidated. Several data support a two-step model. 
Caspase-11 is structurally related to initiator caspases and 
it is likely that molecular scaffolds would similarly control 
its activity. It remains to be determined whether such a 
pathway is conserved in humans and whether caspase-4 
or -5, that both arose from a caspase-11-like ancient gene, 
would participate in a similar cLPS sensing. Such findings 
could create new therapeutic opportunities for sepsis 
treatment. More practically, these new observations 
may significantly change the data interpretation of the 
Gram-negative bacterium infection literature, not only in 
casp1/11 KO mouse studies, but also for many KO studies 
that were carried out using C57BL/6 and 129 mixed 
backgrounds.
Acknowledgements: We thank Drs Nazli Rahim and 
Toufic Renno for critical reading of the manuscript. 
Virginie Petrilli is supported by the French Avenir program 
and la Ligue contre le cancer comité de l’Ain. 
The authors declare that they have no competing 
interest.
Received: October 21, 2013; Accepted: January 17, 2014.
References
[1] McIlwain DR., Berger T., Mak TW., Caspase functions in cell 
death and disease., Cold Spring Harb. Perspect. Biol., 2013, 5, 
a008656 
[2] Lamkanfi M., Declercq W., Kalai M., Saelens X., Vandenabeele 
P., Alice in caspase land. A phylogenetic analysis of caspases 
from worm to man., Cell Death Differ., 2002, 9, 358–61 
[3] Martinon F., Tschopp J., Inflammatory caspases and inflam-
masomes: master switches of inflammation, Cell Death Differ. 
2006/09/16 ed., 2006, 14, 10–22 
[4] Saleh M., Vaillancourt JP., Graham RK., Huyck M., Srinivasula 
SM., Alnemri ES., et al., Differential modulation of endotoxin 
responsiveness by human caspase-12 polymorphisms, Nature. 
2004/05/07 ed., 2004, 429, 75–9 
[5]  Martinon F., Tschopp J., Inflammatory caspases: linking an 
intracellular innate immune system to autoinflammatory 
diseases, Cell., 2004, 117, 561–74 
[6] Martinon F., Burns K., Tschopp J., The inflammasome: a 
molecular platform triggering activation of inflammatory 
caspases and processing of proIL-beta, Mol Cell., 2002, 10, 
417–26 
[7] Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner 
BA., et al., Caspase-12 mediates endoplasmic-reticulum-
specific apoptosis and cytotoxicity by amyloid-beta, Nature. 
2000/01/19 ed., 2000, 403, 98–103 
[8] Saleh M., Mathison JC., Wolinski MK., Bensinger SJ., Fitzgerald 
P., Droin N., et al., Enhanced bacterial clearance and sepsis 
resistance in caspase-12-deficient mice, Nature. 2006/04/21 
ed., 2006, 440, 1064–8 
[9] Wang S., Miura M., Jung YK., Zhu H., Li E., Yuan J., Murine 
caspase-11, an ICE-interacting protease, is essential for the 
activation of ICE, Cell. 1998/03/10 ed., 1998, 92, 501–9 
[10] Agostini L., Martinon F., Burns K., McDermott MF., Hawkins PN., 
Tschopp J., NALP3 forms an IL-1beta-processing inflammasome 
with increased activity in Muckle-Wells autoinflammatory 
disorder, Immunity., 2004, 20, 319–25 
[11] Mariathasan S., Newton K., Monack DM., Vucic D., French DM., 
Lee WP., et al., Differential activation of the inflammasome by 
caspase-1 adaptors ASC and Ipaf, Nature., 2004, 430, 213–8 
[12] Elinav E., Strowig T., Kau AL., Henao-Mejia J., Thaiss C a., Booth 
CJ., et al., NLRP6 inflammasome regulates colonic microbial 
ecology and risk for colitis., Cell., 2011, 145, 745–57 
[13] Vladimer GI., Weng D., Paquette SWM., Vanaja SK., Rathinam 
VAK., Aune MH., et al., The NLRP12 inflammasome recognizes 
Yersinia pestis., Immunity., 2012, 37, 96–107 
[14] Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., 
Horvath G., Caffrey DR., et al., AIM2 recognizes cytosolic 
dsDNA and forms a caspase-1-activating inflammasome with 
ASC, Nature. 2009/01/23 ed., 2009, 458, 514–8 
[15] Fernandes-Alnemri T., Yu JW., Datta P., Wu J., Alnemri ES., AIM2 
activates the inflammasome and cell death in response to 
cytoplasmic DNA, Nature. 2009/01/23 ed., 2009, 458, 509–13 
[16] Martinon F., Gaide O., Petrilli V., Mayor A., Tschopp J., NALP 
inflammasomes: a central role in innate immunity, Semin 
Immunopathol., 2007, 29, 213–29 
[17] Hu Z., Yan C., Liu P., Huang Z., Ma R., Zhang C., et al., Crystal 
structure of NLRC4 reveals its autoinhibition mechanism., 
Science., 2013, 341, 172–5 
[18] Poyet JL., Srinivasula SM., Tnani M., Razmara M., Fernandes-
Alnemri T., Alnemri ES., Identification of Ipaf, a human 
caspase-1-activating protein related to Apaf-1., J. Biol. Chem., 
2001, 276, 28309–13 
[19] Miao EA., Alpuche-Aranda CM., Dors M., Clark AE., Bader MW., 
Miller SI., et al., Cytoplasmic flagellin activates caspase-1 and 
secretion of interleukin 1beta via Ipaf, Nat Immunol., 2006, 7, 
569–75 
[20] Broz P., von Moltke J., Jones JW., Vance RE., Monack DM., 
Differential requirement for Caspase-1 autoproteolysis in 
pathogen-induced cell death and cytokine processing., Cell 
Host Microbe., 2010, 8, 471–83 
[21] Allen IC., Scull M a., Moore CB., Holl EK., McElvania-TeKippe E., 
Taxman DJ., et al., The NLRP3 inflammasome mediates in vivo 
innate immunity to influenza A virus through recognition of 
viral RNA., Immunity., 2009, 30, 556–65 
[22] Hise A., Tomalka J., Ganesan S., Patel K., An Essential Role for 
the NLRP3 Inflammasome in Host Defense against the Human 
Fungal Pathogen Candida albicans, Cell Host Microbe, 2009, 5, 
487–97 
[23] Mariathasan S., Weiss DS., Newton K., McBride J., O’Rourke K., 
Roose-Girma M., et al., Cryopyrin activates the inflammasome 
in response to toxins and ATP., Nature., 2006, 440, 228–32 
[24] Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J., 
Gout-associated uric acid crystals activate the NALP3 
inflammasome., Nature., 2006, 440, 237–41 
[25] Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman 
BT., Tschopp J., Innate immune activation through Nalp3 
inflammasome sensing of asbestos and silica., Science., 2008, 
320, 674–7 
Unauthenticated
Download Date | 11/6/14 9:51 PM
26   Mélanie Bodnar, Virginie Petrilli
containing adaptor inducing interferon-β (TRIF)-mediated 
caspase-11 protease production integrates Toll-like receptor 
4 (TLR4) protein- and Nlrp3 inflammasome-mediated host 
defense against enteropathogens., J. Biol. Chem., 2012, 287, 
34474–83 
[38] Aachoui Y., Leaf I a., Hagar J a., Fontana MF., Campos CG., Zak 
DE., et al., Caspase-11 protects against bacteria that escape 
the vacuole., Science., 2013, 339, 975–8 
[39] Case CL., Kohler LJ., Lima JB., Strowig T., de Zoete MR., Flavell 
R a., et al., Caspase-11 stimulates rapid flagellin-independent 
pyroptosis in response to Legionella pneumophila., Proc. Natl. 
Acad. Sci. U. S. A., 2013, 110, 1851–6 
[40] Casson CN., Copenhaver AM., Zwack EE., Nguyen HT., Strowig 
T., Javdan B., et al., Caspase-11 Activation in Response to 
Bacterial Secretion Systems that Access the Host Cytosol., 
PLoS Pathog., 2013, 9, e1003400 
[41] Broz P., Ruby T., Belhocine K., Bouley DM., Kayagaki N., Dixit 
VM., et al., Caspase-11 increases susceptibility to Salmonella 
infection in the absence of caspase-1., Nature., 2012, 490, 
288–91 
[42] Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda 
Y., et al., Cutting edge: Toll-like receptor 4 (TLR4)-deficient 
mice are hyporesponsive to lipopolysaccharide: evidence 
for TLR4 as the Lps gene product., J. Immunol., 1999, 162, 
3749–52 
[43] Kayagaki N., Wong M., Stowe I., Noncanonical inflammasome 
activation by intracellular LPS independent of TLR4, Science 
(80-. )., 2013, 341, Pages: 1246–9 
[44] Hagar JA., Powell DA., Aachoui Y., Ernst RK., Miao EA., Cytoplasmic 
LPS activates caspase-11: implications in TLR4-independent 
endotoxic shock., Science., 2013, 341, 1250–3 
[45] Schauvliege R., Vanrobaeys J., Schotte P., Beyaert R., 
Caspase-11 gene expression in response to lipopolysaccharide 
and interferon-gamma requires nuclear factor-kappa B and 
signal transducer and activator of transcription (STAT) 1., J. 
Biol. Chem., 2002, 277, 41624–30 
[46] Sander LE., Davis MJ., Boekschoten M V., Amsen D., Dascher 
CC., Ryffel B., et al., Detection of prokaryotic mRNA signifies 
microbial viability and promotes immunity., Nature., 2011, 474, 
385–9
[26] Duewell P., Kono H., Rayner KJ., Sirois CM., Vladimer G., 
Bauernfeind FG., et al., NLRP3 inflammasomes are required for 
atherogenesis and activated by cholesterol crystals., Nature., 
2010, 464, 1357–61 
[27] Faustin B., Lartigue L., Bruey J-MM., Luciano F., Sergienko E., 
Bailly-Maitre B., et al., Reconstituted NALP1 inflammasome 
reveals two-step mechanism of caspase-1 activation, Mol Cell., 
2007, 25, 713–24 
[28] Boyden ED., Dietrich WF., Nalp1b controls mouse macrophage 
susceptibility to anthrax lethal toxin, Nat Genet., 2006, 38, 
240–4 
[29] Zhao Y., Yang J., Shi J., Gong Y-N., Lu Q., Xu H., et al., The 
NLRC4 inflammasome receptors for bacterial flagellin and type 
III secretion apparatus., Nature., 2011, 477, 596–600 
[30] Strowig T., Henao-Mejia J., Elinav E., Flavell R., Inflammasomes 
in health and disease., Nature., 2012, 481, 278–86 
[31] Fink SL., Cookson BT., Apoptosis, pyroptosis, and necrosis: 
mechanistic description of dead and dying eukaryotic cells., 
Infect. Immun., 2005, 73, 1907–16 
[32] Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie 
S., Dong J., et al., Non-canonical inflammasome activation 
targets caspase-11., Nature., 2011, 479, 117–21 
[33] Kang SJ., Wang S., Hara H., Peterson EP., Namura S., 
Amin-Hanjani S., et al., Dual role of caspase-11 in mediating 
activation of caspase-1 and caspase-3 under pathological 
conditions., J. Cell Biol., 2000, 149, 613–22 
[34] Kuida K., Lippke JA., Ku G., Harding MW., Livingston DJ., Su 
MS., et al., Altered cytokine export and apoptosis in mice 
deficient in interleukin-1 beta converting enzyme, Science (80-. 
)., 1995, 267, 2000–3 
[35] Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston 
C., et al., Mice deficient in IL-1 beta-converting enzyme are 
defective in production of mature IL-1 beta and resistant to 
endotoxic shock, Cell., 1995, 80, 401–11 
[36] Rathinam VAK., Vanaja SK., Waggoner L., Sokolovska A., 
Becker C., Stuart LM., et al., TRIF licenses caspase-11-de-
pendent NLRP3 inflammasome activation by gram-negative 
bacteria., Cell., 2012, 150, 606–19 
[37] Gurung P., Malireddi RKS., Anand PK., Demon D., Walle L 
Vande., Liu Z., et al., Toll or interleukin-1 receptor (TIR) domain-
Unauthenticated
Download Date | 11/6/14 9:51 PM
